ARCHIVES

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

NCI clinical trials cooperative group chairmen reject specimen bank contract proposal, endorse cooperative agreements;

January 2, 2004

NCI SBIR Offers $10 million in 10 Awards

February 18, 2011

Schmidt Approve NCAB Authorizations

February 18, 1977

Saffiotti Couldn’t Cope With Demands Of National Program, Rauscher Says In Letter To Kennedy

June 11, 1976

Firm’s Information System Embedded In iKnowMed For Treatment Outcomes.

June 29, 2001

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005